Related Experiment Videos
Toxicity of new spinal agents
1Department of Anesthesiology, Yale University School of Medicine, New Haven, Connecticut.
The Yale Journal of Biology and Medicine
|September 1, 1993
Abstract:
The clinical success of perispinal administration of opiates for pain relief has demonstrated the power of manipulating the neurochemistry of the spinal cord. This article briefly discussed reasons for increased interest in new spinal agents and some of the issues associated with determining their clinical safety.
Insights
Perispinal opiate administration shows promise for pain relief by targeting spinal cord neurochemistry. This review explores new spinal agents and their clinical safety considerations.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Perispinal administration of opiates has shown clinical success for pain relief.
- This highlights the potential of targeting spinal cord neurochemistry for therapeutic effects.
Purpose of the Study:
- To discuss the growing interest in novel spinal agents for pain management.
- To outline key issues in determining the clinical safety of these new agents.
Main Methods:
- Literature review of studies on perispinal administration and spinal agents.
- Analysis of factors influencing the development and safety assessment of new drugs targeting the spinal cord.
Main Results:
- Clinical success of opiate administration via perispinal route.
- Identification of challenges in evaluating the safety of novel spinal agents.
Conclusions:
- The spinal cord is a viable target for pain management therapies.
- Further research is needed to establish robust safety profiles for new spinal agents.